Reflow Medical

Call Directions Website Contact the business

Reflow Medical Reflow Medical, Inc. designs and develops technology used to treat cardiovascular disease.

What do the 12-month DEEPER REVEAL results tell us about treating challenging BTK CLTI?In patients with complex, calcifi...
11/19/2026

What do the 12-month DEEPER REVEAL results tell us about treating challenging BTK CLTI?
In patients with complex, calcified infrapopliteal lesions, treatment with the Spur® Peripheral Retrievable Stent System following predilatation demonstrated sustained clinical outcomes at 12 months:
• Sustained primary patency
• Freedom from clinically driven target lesion revascularization (CD-TLR)
• Complete wound healing and limb salvage

Explore the carousel to discover the key clinical outcomes.

🔗 Learn more about the Spur Stent System:
https://www.reflowmedical.com/spur/

🔗 Important U.S. Safety Information and full Indications for Use:
https://www.reflowmedical.com/resources/

11/18/2026

Reflow Medical is heading to Paris Vascular Insights (PVI) in Paris, France!

Visit us at Booth 11 from December 3–5 to connect with the Reflow Medical team and learn more about our portfolio for the treatment of complex peripheral artery disease.

We're excited to see the Spur® System and Wingman™ CTO Crossing Catheter featured in sessions throughout the congress program, highlighting clinical experience and procedural insights.

Stay tuned for more details on the sessions and presentations in our upcoming posts!

When CTO crossing gets tough, you want a backup you can trust.The Wingman™ CTO Crossing Catheter is designed to step in ...
11/12/2026

When CTO crossing gets tough, you want a backup you can trust.

The Wingman™ CTO Crossing Catheter is designed to step in when standard tools fall short.

With its unique extendable and rotating beveled needle tip, Wingman is designed to help simplify entry into the proximal cap and enable intraluminal CTO crossing.

Its intuitive push-and-twist handle allows controlled anchoring and pe*******on, while the braid-reinforced catheter shaft provides added strength for pushability through difficult lesions and kink resistance.

Bring your Wingman when things get tough.

Learn more about the Wingman™ CTO Crossing Catheter:
US: https://www.reflowmedical.com/wingman/
CE Mark accepting markets: https://www.reflowmedical.com/wingman-eu/

Refer to the Instructions for Use for a complete listing of Indications, Contraindications, Warnings, Precautions, Complications, and Directions for Use:
https://www.reflowmedical.com/resources/

11/11/2026

Rethink BTK treatment.
Watch how Retrievable Scaffold Therapy with Spur® works.

The FDA Breakthrough Device Designated Spur Stent offers a revolutionary approach to BTK treatment. It is intended for the treatment of de novo or restenotic infrapopliteal lesions following predilatation.

Through mechanical scaffolding and radially expandable spikes, Spur supports the vessel wall, facilitates blood flow, and enables controlled lesion pe*******on and modification to improve vessel compliance and reduce recoil.

Following treatment, the device is fully retrieved.

Learn more about Spur® (link in bio).

Full U.S. Indications for Use:
https://www.reflowmedical.com/resources/

11/09/2026

Exploring new perspectives in BTK treatment? Let's connect at VEITH 2026!
Visit us at Booth #413 to discuss Retrievable Scaffold Therapy (RST) with the Spur® System for BTK disease and explore our peripheral portfolio, including the Wingman™ CTO Crossing Catheter.

Don't miss Prof. Thomas Zeller, MD, presenting the latest findings from DEEPER OUS and DEEPER REVEAL, investigating the Spur® System as a definitive treatment and in combination with Drug-Coated Balloon (DCB) Technology.

Wednesday, November 18 | 8:41 AM
Grand Ballroom East, 3rd Floor | Session 24

See you in New York!

Long-Term Evidence for Spur® + PTX DCB in BTK DiseaseFour-year outcomes from the DEEPER OUS study provide long-term insi...
11/06/2026

Long-Term Evidence for Spur® + PTX DCB in BTK Disease
Four-year outcomes from the DEEPER OUS study provide long-term insights into Spur® Retrievable Scaffold Therapy (RST) in combination with a paclitaxel-coated drug-coated balloon (PTX DCB) in infrapopliteal lesions.

These findings provide valuable insights into treatment strategies aimed at improving long-term outcomes for patients with BTK disease.

Swipe through the carousel to explore the key findings and four-year clinical outcomes.

Learn more about Spur®
https://www.reflowmedical.com/spur/

For a complete listing of the Indications, Contraindications, Warnings, Precautions, Complications, and Directions for Use, please refer to the applicable U.S. and CE Instructions for Use (IFU):
https://www.reflowmedical.com/resources/

Thank you, TCT 2026! It was a privilege to have Retrievable Scaffold Therapy (RST) on the program.First time presented! ...
11/04/2026

Thank you, TCT 2026! It was a privilege to have Retrievable Scaffold Therapy (RST) on the program.

First time presented! We were thrilled to see results from DEEPER CORONARY, our first-in-human study evaluating the investigational coronary Spur® Elute for the treatment of coronary in-stent restenosis, presented on the Innovation stage.

Our gratitude to Dr. Kathleen Kearney of Beth Israel Deaconess Medical Center and Harvard Medical School, who presented the findings on behalf of principal investigator Prof. Scott Harding, director of the Cardiology Research Group at Wellington Hospital in New Zealand.

We also thank Dr. Dejan Mancevski for bringing a below-the-knee case featuring RST with Spur® to the Cases with the Masters stage.

A big thank you to the TCT organizers for a program that keeps innovation front and center!

What’s behind the spin?Cora Flex® and Cora Force® share a platform featuring our proprietary Cora Tech™ technology. This...
11/03/2026

What’s behind the spin?
Cora Flex® and Cora Force® share a platform featuring our proprietary Cora Tech™ technology. This unique technology sets a new standard for coronary torqueable microcatheters.

In bench testing, Cora Tech™ demonstrated the highest bi-directional spinning freedom and best torque transmission compared with market leaders.*

Available in two distinct versions for different lesion types, Cora Flex® is designed to reach and cross the tightest lesions, while Cora Force® provides maximum tip force support for engaging heavily calcified and fibrotic lesions.

Learn more about our next-generation torqueable microcatheters:
https://www.reflowmedical.com/coracatheters/

Full U.S. Indications for Use:
https://www.reflowmedical.com/resources/

*Data on file. Bench testing assessed rotations until loss of guidewire maneuverability as well as peak torque transmission.

Thank you to everyone who shared insights about the Spur® Peripheral Retrievable Stent System and the mechanical effects...
10/29/2026

Thank you to everyone who shared insights about the Spur® Peripheral Retrievable Stent System and the mechanical effects of Retrievable Scaffold Therapy (RST) at AMP Europe.

We were thrilled to see Bruno Migliara, MD, on stage with “Beyond Angiography: Understanding Vessel Response with the Novel Spur,” walking through how RST reduces vessel recoil and changes vessel compliance, closing with pre- and post-procedure angiograms showing a healed wound at three months.

A thank you also to the poster authors. K. Kurzmann-Guetl, MD, independently submitted a poster on the DEEPER CHALLENGE study, an investigator-initiated trial evaluating early recoil in specific CLTI populations. A second poster, from S. Jay Mathews, MD, et al., shared 12-month outcomes from the DEEPER REVEAL clinical trial.

And to Tim Wittig, MD, whose presentation, “A New Tool for Crossing CTOs,” featured the Wingman CTO Crossing Catheter.

We’re proud to see the Reflow Medical portfolio part of the conversation at a program like this.

Thank you, AMP Europe.

Stent-like results. Nothing left behind.In a new case report, Karthikeshwar Kasirajan, MD, demonstrates how the Spur® Pe...
10/28/2026

Stent-like results. Nothing left behind.

In a new case report, Karthikeshwar Kasirajan, MD, demonstrates how the Spur® Peripheral Retrievable Stent System delivered a stent-like result in a heavily calcified BTK lesion while restoring flow to the foot.

At procedure completion:
• Residual stenosis reduced from 95% to less than 20%
• Restored flow to the foot achieved
• No permanent implant left behind in the treated BTK vessel

📄 Swipe through to see the case and outcomes.

Address

208 Avenida Fabricante, Ste. 100
San Clemente, CA
92672

Alerts

Be the first to know and let us send you an email when Reflow Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Reflow Medical:

Shortcuts

Share

Nearby businesses